Charcot-Marie-Tooth disease
MONDO:0015626An inherited degenerative disorder involving the peripheral nerves. It is caused by mutations in the genes that are responsible for the production of proteins necessary for the function and structure of the peripheral nerves. It is characterized by muscle atrophy and weakness in the feet, legs, hands, and arms and loss of sensation in the limbs.
Also known as: hereditary motor and sensory neuropathy, hereditary sensorimotor neuropathy, CMT, CMT/HMSN, Charcot Marie Tooth muscular atrophy, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth hereditary neuropathy, peroneal muscular atrophy
82 clinical trials for this condition and its sub-types, 51 tagged with Charcot-Marie-Tooth disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Charcot-Marie-Tooth disease
-
Charcot-Marie-Tooth disease type 1 4 trials · 40 incl. sub-types
6 sub-types
- Charcot-Marie-Tooth disease type 1F 21 trials
- Charcot-Marie-Tooth disease type 1A 16 trials
- Charcot-Marie-Tooth disease type 1B 3 trials
- Charcot-Marie-Tooth disease type 1C 1 trial
- Charcot-Marie-Tooth disease type 1D 1 trial
- Charcot-Marie-Tooth disease type 1E 1 trial
-
Charcot-Marie-Tooth disease type 2 3 trials · 9 incl. sub-types
39 sub-types
- Charcot-Marie-Tooth disease axonal type 2S 3 trials
- Charcot-Marie-Tooth disease type 2A1 2 trials
- Charcot-Marie-Tooth disease type 2A2 2 trials
- Charcot-Marie-Tooth disease type 2D 2 trials
- Charcot-Marie-Tooth disease type 2J 2 trials
- Charcot-Marie-Tooth disease axonal type 2C 1 trial
- Charcot-Marie-Tooth disease axonal type 2H 1 trial
- Charcot-Marie-Tooth disease axonal type 2L 1 trial
- Charcot-Marie-Tooth disease axonal type 2N 1 trial
- Charcot-Marie-Tooth disease axonal type 2O 1 trial
- Charcot-Marie-Tooth disease axonal type 2P 1 trial
- Charcot-Marie-Tooth disease axonal type 2Q 1 trial
- Charcot-Marie-Tooth disease axonal type 2U 1 trial
- Charcot-Marie-Tooth disease type 2B1 1 trial
- Charcot-Marie-Tooth disease type 2B2 1 trial
- Charcot-Marie-Tooth disease type 2B5 1 trial
- Charcot-Marie-Tooth disease type 2E 1 trial
- Charcot-Marie-Tooth disease type 2I 1 trial
- Charcot-Marie-Tooth disease type 2R 1 trial
- Charcot-Marie-Tooth disease type 2T 1 trial
- Charcot-Marie-Tooth disease type 2Y 1 trial
- Autosomal dominant Charcot-Marie-Tooth disease type 2K 1 trial
- Autosomal dominant Charcot-Marie-Tooth disease type 2M 1 trial
- Charcot-Marie-Tooth disease axonal type 2CC 0 trials
- Charcot-Marie-Tooth disease axonal type 2F 0 trials
- Charcot-Marie-Tooth disease axonal type 2K 0 trials
- Charcot-Marie-Tooth disease axonal type 2T 0 trials
- Charcot-Marie-Tooth disease axonal type 2V 0 trials
- Charcot-Marie-Tooth disease axonal type 2X 0 trials
- Charcot-Marie-Tooth disease axonal type 2Z 0 trials
- Charcot-Marie-Tooth disease type 2B 0 trials
- Charcot-Marie-Tooth disease, axonal, type 2EE 0 trials
- Charcot-Marie-tooth disease, axonal, type 2DD 0 trials
- MME-related autosomal dominant Charcot Marie Tooth disease type 2 0 trials
- Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation 0 trials
- Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation 0 trials
- Autosomal dominant Charcot-Marie-Tooth disease type 2W 0 trials
- Autosomal dominant charcot-marie-tooth disease type 2 due to DGAT2 mutation 0 trials
- Giant axonal neuropathy 2 0 trials
-
Charcot-Marie-Tooth disease type 4 0 trials · 5 incl. sub-types
12 sub-types
- Charcot-Marie-Tooth disease type 4J 3 trials
- Charcot-Marie-Tooth disease type 4A 2 trials
- Charcot-Marie-Tooth disease type 4B1 2 trials
- Charcot-Marie-Tooth disease type 4B2 2 trials
- Charcot-Marie-Tooth disease type 4C 2 trials
- Charcot-Marie-Tooth disease type 4D 2 trials
- Charcot-Marie-Tooth disease type 4B3 1 trial
- Charcot-Marie-Tooth disease type 4E 1 trial
- Charcot-Marie-Tooth disease type 4F 1 trial
- Charcot-Marie-Tooth disease type 4H 1 trial
- Charcot-Marie-Tooth disease type 4G 0 trials
- Charcot-Marie-Tooth disease type 4K 0 trials
-
Intermediate Charcot-Marie-Tooth disease 0 trials · 3 incl. sub-types
3 sub-types
- Autosomal dominant intermediate Charcot-Marie-Tooth disease 0 trials · 3 incl. sub-types Sub-types →
- Autosomal recessive intermediate Charcot-Marie-Tooth disease 0 trials · 2 incl. sub-types Sub-types →
- Charcot-Marie-Tooth disease, dominant intermediate G 0 trials
-
Charcot-Marie-Tooth disease type X 1 trial · 2 incl. sub-types
6 sub-types
- Charcot-Marie-Tooth disease X-linked dominant 1 1 trial
- Charcot-Marie-Tooth disease X-linked dominant 6 0 trials
- Charcot-Marie-Tooth disease X-linked recessive 2 0 trials
- Charcot-Marie-Tooth disease X-linked recessive 3 0 trials
- Charcot-Marie-Tooth disease X-linked recessive 4 0 trials
- Charcot-Marie-Tooth disease X-linked recessive 5 0 trials
-
Charcot-Marie-Tooth disease type 3 0 trials
Most studied deeper sub-types
-
Blood test may forecast brain recovery after cardiac arrest
Knowledge-focused Not yet recruitingThis study investigates whether levels of a protein called neurofilament light chain (NFL) in the blood can predict neurological recovery in people who remain comatose after a cardiac arrest. Researchers will measure NFL at several time points over the first week in the ICU and c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Wearable sensors could transform CMT1A monitoring
Knowledge-focused Not yet recruitingThis study will use wearable activity trackers to measure how much people with Charcot-Marie-Tooth disease type 1A (CMT1A) move at home. Researchers want to see if sensor data matches standard clinical tests. The goal is to improve patient follow-up and support future trials of n…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can blood tests spot Alzheimer's risk in all ethnicities? barcelona study aims to find out
Knowledge-focused Not yet recruitingThis study will check if levels of Alzheimer's-related substances in the blood differ among the main ethnic groups living in central Barcelona. Researchers will also look at how age, income, education, and health conditions affect these levels. The goal is to identify barriers to…
Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Exercise may shield MS brains from damage, small trial hopes to show
Knowledge-focused Not yet recruitingThis study will test whether a 12-week progressive resistance training program can improve brain health in people with relapsing-remitting multiple sclerosis. Researchers will measure brain volume and a nerve damage marker in the blood. The trial involves 26 participants and aims…
Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Which works better for CMT foot problems: surgery or therapy alone?
Knowledge-focused Not yet recruitingThis study looks at two ways to help people with Charcot-Marie-Tooth disease (CMT) walk better. One group gets foot surgery followed by rehabilitation, the other gets only physical therapy. Researchers will track walking speed and endurance for up to two years to see which approa…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study aims to unravel fatigue in common nerve disease
Knowledge-focused Not yet recruitingThis pilot study looks at fatigue in people with Charcot-Marie-Tooth type 1A (CMT1A), a nerve disorder affecting arms and legs. Researchers will compare 22 patients with 22 healthy volunteers to measure how fatigue affects walking and balance. They use tests like muscle strength …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New blood test may predict brain damage in Oxygen-Deprived newborns
Knowledge-focused Not yet recruitingThis study looks at whether a protein called neurofilament light chain (NfL) in the blood can help measure brain injury in newborns with hypoxic-ischemic encephalopathy (HIE), a condition caused by lack of oxygen at birth. Researchers will measure NfL levels at several time point…
Sponsor: Mustafa Gürkan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC